Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled Infectokrupp vs Fastjekt Junior for acute anaphylaxis in infants during food challenge
DRKS00011881Phase 2Completed
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Jun 2017
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of epinephrine in anaphylactic shock (2 arms), sponsored by Charité – Universitätsmedizin Berlin. Primary endpoints: Efficacy of inhaled vs intramuscular epinephrine, Safety of inhaled vs intramuscular epinephrine and 1 more. Started Jun 2017; status: completed.
02
Drugs
epinephrine
03
Conditions
anaphylactic shock
Beyond the preview
Go deeper on DRKS00011881.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00011881.